UMIN ID: UMIN000014997
Registered date:29/08/2014
Rituxan injection drug use-results survey in patients with complicated nephrotic syndrome
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | nephrotic symdrome |
Date of first enrollment | 2014/08/29 |
Target sample size | 300 |
Countries of recruitment | Japan |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | Adverse drug reaction occurrences Relapse-free period |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | None |
Related Information
Primary Sponsor | Zenyaku Kogyo, Co., Ltd. |
---|---|
Secondary Sponsor | Chugai Pharmaceutical Co., Ltd. |
Source(s) of Monetary Support | Zenyaku Kogyo, Co., Ltd. |
Secondary ID(s) |
Contact
public contact | |
Name | Shohji Kimura |
Address | 6-15, Otsuka 5-chome, Bunkyo-ku, Tokyo 112-8650 Japan |
Telephone | 03-3946-1136 |
Shohji_Kimura@mail.zenyaku.co.jp | |
Affiliation | Zenyaku Kogyo, Co., Ltd. Post-Marketing-Surveillance Pharmacovigilance & Quality Assurance Department |
scientific contact | |
Name | Shohji Kimura |
Address | 6-15, Otsuka 5-chome, Bunkyo-ku, Tokyo 112-8650 Japan |
Telephone | 03-3946-1136 |
Shohji_Kimura@mail.zenyaku.co.jp | |
Affiliation | Zenyaku Kogyo, Co., Ltd. Post-Marketing-Surveillance Pharmacovigilance & Quality Assurance Department |